“…England, Israel, Norway, Australia, New Zealand, Scotland, Sweden, Denmark, Switzerland and the United States) in the care and management of clients with severe and persistent mental illness, most frequently schizophrenia, who have a history of treatment non‐compliance and subsequent relapse (Rugkåsa, ). There is ongoing controversy around their use: clinically, they may result in greater long‐term stability (Hunt, Da Silva, Lurie, & Goldbloom, ; Karagianis, ; Nakhost, Perry, & Frank, ); however, they also negatively affect individuals’ sense of autonomy, increase feelings of stigmatization and shame (Light et al, ; Strenstrud, Høyer, Granerud, & Landheim, ), and impose a disadvantageous identity (Barron, ). International disability rights legislation has recognized the need to address SMI in a way that does not involve coercion (United Nations, ; Wildeman, ), and yet the use of CTOs continues to be on the rise (Deridder, Molodynski, Manning, Mccusker, & Rugkåsa, ; Psychiatric Patients Advocate Office, ).…”